Nutrition and inflammatory bowel disease;Nutrición y enfermedad inflamatoria intestinal

Nutricion Hospitalaria

Volumn 22, Issue SUPPL. 2, 2007, Pages 65-73

  Cabré Gelada, Eduard ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Antioxidants; Crohn's disease; Diet; Dietary fibre; Enteral nutrition; Malnutrition; Parenteral nutrition; Trace elements; Ulcerative colitis; Vitamins

Indexed keywords

ARTICLE; CROHN DISEASE; DIETARY FIBER; ENTERIC FEEDING; ENTERITIS; HUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PATIENT COUNSELING; ULCERATIVE COLITIS; PROTEIN CALORIE MALNUTRITION; REVIEW;

ENTERAL NUTRITION; HUMANS; INFLAMMATORY BOWEL DISEASES; NUTRITIONAL SUPPORT; PROTEIN-ENERGY MALNUTRITION;

EID: 35548980473     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. nd ed). London: Greenwich Medical Media, 2001: 553-573.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347:417-429.
3. Body JJ. The syndrome of anorexia-cachexia. Curr Opin Oncol 1999; 11:255-260.
4. Ballinger AB, El-Haj T, Perrett D, Turvill JL, Obeid O, Dryden S y cols. The role of medial hypothalamic serotonin in the supression of feeding in a rat model of colitis. Gastroenterology 2000; 118:544-553.
5. El Haj T, Poole S, Farthing MJ, Ballinger AB. Anorexia in a rat model of colitis: interaction of interleukin-1 and hypothalamic serotonin. Brain Res 2002; 927:1-7.
6. Klein S, Meyers S, O'Sullivan P, Barton D, Leleiko N, Janowitz HD. The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balance. J Clin Gastroenterol 1988; 10:34-40.
7. Kushner RF, Schoeller DA. Resting and total energy expenditure in patients with inflammatory bowel disease. Am J Clin Nutr 1991; 53:161-165.
8. Stokes MA, Hill GL. Total Energy Expenditure in Patients with Crohn's Disease - Measurement by the Combined Body Scan Technique. JPEN 1993; 17:3-7.
9. Azcue M, Rashid M, Griffiths A, Pencharz PB. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut 1997; 41:203-208.
10. Chan ATH, Fleming R, O'Fallon WM, Huitzenga KA. Estimated versus measured basal energy requirements in patients with Crohn's disease. Gastroenterology 1986; 91:75-80.
11. Rigaud D, Cerf M, Alberto LA, Sobhani I, Carduner MJ, Mignon M. Augmentation de la dépense énergétique de repos lors des poussées de la maladie de Crohn. Gastroenterol Clin Biol 1993; 17:932-937.
12. Schneeweiss B, Lochs H, Zauner C, Fischer M, Wyatt J, Maier-Dobersberger T y cols. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr 1999; 129:844-848.
13. Al-Jaouni R, Hébuterne X, Pouget I, Rampal P. Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition 2000; 16:173-178.
14. Mingrone G, Capristo E, Greco AV, Benedetti G, De Gaetano A, Tataranni PA y cols. Elevated diet-induced thermogenesis and lipid oxidation rate in Crohn's disease. Am J Clin Nutr 1999; 69:325-330.
15. Biancone L, Fantini M, Tosti C, Bozzi R, Vavassori P, Pallone F. Fecal alpha1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum. Eur J Gastroenterol Hepatol 2003; 15:261-266.
16. Markowitz J, Daum F. Growth impairment in pediatric inflammatory bowel disease. Am J Gastroenterol 1994; 89:319-326.
17. Griffiths AM, Nguyen P, Smith C, MacMillan JH, Sherman PM. Growth and clinical course of children with Crohn's disease. Gut 1993; 34:939-943.
18. Semeao EJ, Jawad AF, Stouffer NO, Zemel BS, Piccoli DA, Stallings VA. Risk factors for low bone mineral density in children and young adults with Crohn's disease. J Pediatr 1999; 135:593-600.
19. Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbruegger RW, Brummer RJM. Bone mineral density in patients with recently diagnosed inflammatory bone disease. Gastroenterology 2000; 119:1203-1208.
20. Bernstein CN, Leslie WD, Taback SP. Bone density in a population-based cohort of premenopausal adult women with early onset inflammatory bowel disease. Am J Gastroenterol 2003; 98:1094-1100.
21. Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 2000; 247:63-70.
22. García-Planella E, Mañosa M, Domènech E, Holgado S, Cabré E, Gassull MA. Estudio transversal de la prevalencia y factores asociados a las alteraciones de la densidad mineral ósea en pacientes con enfermedad inflamatoria intestinal. Gastroenterol Hepatol 2003; 26:178-179 (abstract).
23. Fernández Bañares F, Abad Lacruz A, Xiol X, Giné JJ, Dolz C, Cabré E y cols. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 1989; 84:744-746.
24. Fernández Bañares F, Mingorance MD, Esteve M, Cabré E, Lachica M, Abad Lacruz A y cols. Serum zinc, copper, and selenium levels in inflammatory bowel disease: effect of total enteral nutrition on trace element status. Am J Gastroenterol 1990; 85:1584-1589.
25. Geerling BJ, Badart-Smook A, Stockbruegger RW, Brummer RJM. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000; 54:514-521.
26. Geerling BJ, Badart-Smook A, Stockbruegger RW, Brummer RJM. Comprehensive nutritional status in patients with long-standing Crohn's disease currently in remission. Am J Clin Nutr 1998; 67:919-926.
27. Reimund JM, Hirth C, Koehl C, Baumann R, Duclos B. Antioxidant and immune status in active Crohn's disease. A possible relationship. Clin Nutr 2000; 19:43-48.
28. Chowers Y, Sela BA, Holland R, Fidder H, Simoni FB, Bar-Meir S. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol 2000; 95:3498-3502.
29. Romagnuolo J, Fedorak RN, Dias VC, Bamforth F, Teltscher M. Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study. Am J Gastroenterol 2001; 96:2143-2149.
30. Ballegaard M, Bjerstrom A, Brondum E, Hylander E, Jensen L, Ladefoged K. Self-reported food intolerance in chronic inflammatory bowel disease. Scand J Gastroenterol 1997; 37:569-571.
31. Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Clin Nutr 2004; 23:161-170.
32. Pearson M, Teahon K, Levi AJ, Bjarnason I. Food intolerance and Crohn's disease. Gut 1993; 34:783-787.
33. Alun Jones V, Workmann EM, Dickinson RJ, Wilson AJ, Hunter JO. Crohn's disease: maintenance of remission by diet. Lancet 1985; 2:177-180.
34. Riordan AM, Hunter JO, Cowan RE, Crampton JR, Davidson AR, Dickinson RJ y cols. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 1993; 342:1131-1134.
35. Greenberg GR, Fleming CR, Jeejeebhoy KN, Rosenberg IH, Sales D, Tremaine WJ. Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut 1988; 29:1309-1315.
36. McIntyre PB, Powell-Tuck J, Wood SR, Lennard-Jones JE, Lerebours E, Hecketsweiler P y cols. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 1986; 27:481-485.
37. González-Huix F, Fernández Bañares F, Esteve Comas M, Abad Lacruz A, Cabré E, Acero D y cols. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol 1993; 88:227-232.
38. Rosinach M, Maurer A, Domènech E, Deselaers A, García-Planella E, Bernal I y cols. ¿Es necesario suprimir los lácteos de la dieta en los brotes de actividad de enfermedad inflamatoria intestinal? Gastroenterol Hepatol 2002; 25:198-199 (abstract).
39. Roediger WEW. The colonic epithelium in ulcerative colitis: an energy-deficient disease? Lancet 1980; 2:712-715.
40. Chapman MAS, Grahn MF, Boyle MA, Hutton M, Rogers J, Williams NS. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994; 35:73-76.
41. Kim Y. Short-chain fatty acids in ulcerative colitis. Nutrition Rev 1998; 56:17-24.
42. Den Hond E, Hiele M, Evenpoel P, Peeters M, Ghoos Y, Rutgeerts P. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 1998; 115:548-590.
43. Simpson EJ, Chapman MAS, Dawson J, Berry D, MacDonald IA, Colen A. In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Gut 2000; 46:73-77.
44. Inan MS, Rasoulpour EJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C. The luminal short-chain fatty acid butyrate modulates NF-kB activity in a human colonic epithelial cell line. Gastroenterology 2000; 118:724-734.
45. Segain JP, Raingeard de la Blétière D, Bourreille A, Leray V, Gervois N, Rosales C y cols. Butyrate inhibits inflammatory responses through NFkB inhibition: implications for Crohn's disease. Gut 2000; 47:397-403.
46. Vernia P, Caprilli R, Latella G, Barbetti F, Magliocca FM, Cittadini M. Fecal lactate and ulcerative colitis. Gastroenterology 1988; 95:1564-1568.
47. Fernández Bañares F, Hinojosa J, Gomollón F, Sánchez-Lombraña JL, Rodríguez-Abascal J, Gassull MA y cols. Randomized clinical trial of Plantago ovata (dietary fibre) as compared to mesalamine in maintaining remission in ulcerative colitis. Am J Gastroenterol 1999; 94:427-433.
48. Fernández Bañares F, Fluvià L, Hernández JM, Navarro E, Gassull MA. In vitro fermentation of different types of dietary fiber in ulcerative colitis: production of butyrate. Gastroenterology 2000; 118:A853 (abstract).
49. Gassull MA, Abad A, Cabré E, González-Huix F, Giné JJ, Dolz C. Enteral nutrition in inflammatory bowel disease. Gut 1986; 27(Suppl 1):76-80.
50. Fernández Bañares F, Cabré E, Esteve Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN 1995; 19:356-364.
51. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Metaanalysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995; 108:1056-1067.
52. Messori A, Trallori G, D'Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease - A meta-analysis. Scand J Gastroenterol 1996; 31:267-272.
53. Singleton JW, Hanauer SB, Gitnick GL, Peppercorn MA, Robinson MG, Wruble LD y cols. Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial. Gastroenterology 1993; 104:1293-1301.
54. Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson ABR, Williams CN y cols. Oral budesonide for active Crohn's disease. N Engl J Med 1994; 331:836-841.
55. Gassull MA. Diet or steroids? En: Jewell DP, Mortensen N, Warren BF, editors. Challenges in Inflammatory Bowel Disease. Oxford: Blackwell Science, 2001: 111-120.
56. Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Ped Gastroenterol Nutr 2000; 30:78-84.
57. Fernández Bañares F, Cabré E, González-Huix F, Gassull MA. Enteral nutrition as primary therapy in Crohn's disease. Gut 1994; 35:S55-S59.
58. Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr 1995; 14:229-236.
59. Steinhart AH, Greenberg GR. Nutrition in inflammatory bowel disease. Curr Opin Gastroen 1997; 13:140-145.
60. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000; 71(Suppl):343S-348S.
61. Gassull MA, Fernández-Bañares F, Cabré E, Papo M, Giaffer MH, Sánchez-Lombraña JL y cols. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002; 51:164-168.
62. González-Huix F, De León R, Fernández Bañares F, Esteve M, Cabré E, Acero D y cols. Polymeric enteral diet as primary treatment of active Crohn's disease - A prospective steroid-controlled trial. Gut 1993; 34:778-782.
63. Aiges H, Markowitz J, Rosa J, Daum F. Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease. Gastroenterology 1989; 97:905-910.
64. Belli DC, Seidman E, Bouthillier L, Weber AM, Roy CC, Pletincx M y cols. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988; 94:603-610.
65. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Ped Gastroenterol Nutr 2000; 31:8-15.
66. Griffiths AM. Enteral nutrition: the neglected primary therapy of Crohn's disease. J Ped Gastroenterol Nutr 2000; 31:3-5.